-
ERADECs Hijack ERAD to Degrade Transmembrane Proteins
2026-09-21
Song and colleagues establish ERAD-engaging chimeras (ERADECs), a small-molecule platform that redirects the endoplasmic reticulum degradation pathway toward transmembrane proteins. By using desonide to engage the ER E3 ligase SYVN1, the study achieves potent PD-L1 degradation, tumor suppression, and degradation of mutant huntingtin, while defining a new route for targeted protein degradation.
-
Cimetidine in BBB Assays: From H2R to Data
2026-09-21
Cimetidine can connect H2 receptor pharmacology with mechanism-aware blood-brain barrier experiments. This guide shows how to interpret permeability, efflux, recovery, and lysosomal-trapping data without overstating implications for cancer research.
-
5-EdU: A Mechanistic Readout for Tumor Biology
2026-09-20
5-Ethynyl-2'-deoxyuridine (5-EdU) is more than a proliferation label: it is a functional window into S phase DNA synthesis, treatment response, and tumor-cell state. This thought-leadership article connects 5-EdU workflow design with recent evidence on CDK4/6 and BET inhibition in pancreatic cancer, while outlining practical strategies for translational researchers and the limitations that matter when moving from cell culture to tissue models.
-
Y-27632 ROCK Inhibitor: Workflow Guide
2026-09-19
Y-27632 provides selective ROCK1 and ROCK2 inhibition for connecting actin remodeling with cell recovery, organoid handling, and hepatocyte-state assays. This practical guide translates the LPS–TLR4–YAP1 findings of a liver stemness study into controlled perturbation workflows while separating established evidence from assay-development recommendations.
-
AG-126: ERK Pathway Workflows for Translational Studies
2026-09-19
AG-126 enables controlled interrogation of ERK1/2 phosphorylation, cytokine output, and pathway-linked phenotypes in cell-based assays. This guide connects established inflammatory applications with a carefully bounded neuroscience extension inspired by Neuroligin 1 and striatal D2-MSN research.
-
EZ Cap EGFP mRNA 5-moUTP: Assay Design Guide
2026-09-18
EZ Cap EGFP mRNA 5-moUTP provides a defined reporter system for studying delivery, translation, and fluorescent protein expression. This guide explains how Cap1, 5-moUTP, poly(A) architecture, and formulation variables shape interpretable mRNA assays.
-
A 83-01 in Bovine Liver Organoid Assays
2026-09-18
A 83-01 is an ALK-5 inhibitor that can add causal pathway resolution to bovine liver organoid models of fatty liver. This guide connects TGF-β biology with lipid, inflammatory, and organoid assay design while separating established evidence from testable workflow recommendations.
-
Sphingosine-1-phosphate: Applied Signaling Workflows
2026-09-17
Build reproducible S1P experiments for receptor signaling, endothelial behavior, and neuronal apoptosis. This practical guide connects affinity-informed dosing with orthogonal readouts, vehicle controls, and the S1PR3–TNF-α–caspase-3 findings reported after intracerebral hemorrhage.
-
Vancomycin in Microbiome–Immune Research
2026-09-17
Vancomycin is a glycopeptide antibiotic with value beyond antibacterial assays: it can serve as a defined microbiome perturbation tool. This article connects its cell-wall mechanism with the Lactobacillus–UDCA–immune findings in ulcerative colitis research while emphasizing assay controls and interpretive limits.
-
Recombinant Annexin V for Apoptosis Detection
2026-09-16
Brumatti, Sheridan, and Martin present a practical bacterial expression and purification workflow for recombinant polyhistidine-tagged annexin V, followed by FITC conjugation and fluorescence-based apoptosis detection. The study’s main contribution is a reproducible route to a soluble, high-yield phosphatidylserine probe that can be applied in flow cytometry and fluorescence microscopy, while also clarifying important interpretation limits.
-
BH3-Mimetic Targeting in Glioblastoma
2026-09-15
The reference study shows that glioblastoma is unusually dependent on anti-apoptotic BCL-xL and MCL-1, particularly within stem-like tumor cell populations. Its central translational insight is that sequential disruption of these survival dependencies can produce strong antitumor responses in vivo without overt toxicity, providing a mechanistic framework for biomarker-guided BH3-mimetic research.
-
Pam3CSK4 TFA: From Signal to Biomarker
2026-09-15
Pam3CSK4 TFA is a defined TLR1/2 agonist for separating receptor-specific innate signaling from complex microbial effects. This guide connects assay design with maternal-neonatal GBS cytokine findings, emphasizing how to interpret IL-17A without overclaiming causality.
-
Hexa His tag peptide: Reliable Workflow Guide
2026-09-14
This scenario-based guide explains how Hexa His tag peptide (SKU A6006) can improve competitive elution, His-tagged protein purification, and interaction-analysis workflows without overstating its role in cell-viability assays. It provides practical selection, handling, and interpretation guidance grounded in the product specification and relevant protein-interaction literature.
-
2'3'-cGAMP: From STING Signal to Strategy
2026-09-13
A translational framework for using 2'3'-cGAMP (sodium salt) as a mechanistic benchmark and design component in STING-mediated innate immune response studies, with evidence from a multifunctional nanovaccine study and practical guidance for immunotherapy research.
-
A 83-01: From ALK-5 Inhibition to Organoids
2026-09-12
Patient-derived organoids offer a practical bridge between pathway biology and translational testing. This article examines how A 83-01, a selective ALK-5 inhibitor, can help researchers interrogate TGF-β/Smad signaling, EMT, and drug response in rare breast tumor models while preserving appropriate experimental caution.